(UroToday.com) Haematuria is among the most common presentations from primary care to the urology clinic. The underlying rate of malignancy varies according to the severity of haematuria and tumor site. There is significant variation in the evaluation of patients with haematuria between countries, particularly with respect to imaging of the upper tract. In a moderated poster presentation at the American Urologic Association (AUA) 2020 Virtual Annual Meeting, Kevin Gallagher and colleagues assessed the prevalence of urinary tract cancer (UTC) among patients seen for haematuria in secondary care. Secondary aims were to explore reasons for differences in prevalence between countries.